2
Total Mentions
2
Documents
0
Connected Entities
Name reference in documents
EFTA00300912
ted one year, it was higher than the bid. Is that because of the tax inversion? CE: That's what it was—it was the tax inversion. It was because AbbVie was scared of getting yelled at by Obama. So they blew it up. They traded from $250 to $150. Settled around $180 for the next two or three month
EFTA01371392
only shelters income at capital gain rates. The termination fee at issue in one of the rulings is believed to relate to the terminated 2014 proposed AbbVie Inc.-Shire Plc merger where a termination fee in excess of $1.5 billion was paid. Based upon recent comments by the IRS, it appears they placed sig
No connected entities